uPAR-induced cell adhesion and migration: vitronectin provides the key
Chris D Madsen, Gian Maria Sarra Ferraris, Annapaola Andolfo, Orla Cunningham, Nicolai Sidenius, Chris D Madsen, Gian Maria Sarra Ferraris, Annapaola Andolfo, Orla Cunningham, Nicolai Sidenius
Abstract
Expression of the membrane receptor uPAR induces profound changes in cell morphology and migration, and its expression correlates with the malignant phenotype of cancers. To identify the molecular interactions essential for uPAR function in these processes, we carried out a complete functional alanine scan of uPAR in HEK293 cells. Of the 255 mutant receptors characterized, 34 failed to induce changes in cell morphology. Remarkably, the molecular defect of all of these mutants was a specific reduction in integrin-independent cell binding to vitronectin. A membrane-tethered plasminogen activator inhibitor-1, which has the same binding site in vitronectin as uPAR, replicated uPAR-induced changes. A direct uPAR-vitronectin interaction is thus both required and sufficient to initiate downstream changes in cell morphology, migration, and signal transduction. Collectively these data demonstrate a novel mechanism by which a cell adhesion molecule lacking inherent signaling capability evokes complex cellular responses by modulating the contact between the cell and the matrix without the requirement for direct lateral protein-protein interactions.
Figures
References
- Aguirre Ghiso, J.A., K. Kovalski, and L. Ossowski. 1999. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J. Cell Biol. 147:89–104.
- Alfano, M., N. Sidenius, B. Panzeri, F. Blasi, and G. Poli. 2002. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication. Proc. Natl. Acad. Sci. USA. 99:8862–8867.
- Barinka, C., G. Parry, J. Callahan, D.E. Shaw, A. Kuo, K. Bdeir, D.B. Cines, A. Mazar, and J. Lubkowski. 2006. Structural basis of interaction between urokinase-type plasminogen activator and its receptor. J. Mol. Biol. 363:482–495.
- Blasi, F., and P. Carmeliet. 2002. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3:932–943.
- Chaurasia, P., J.A. Aguirre-Ghiso, O.D. Liang, H. Gardsvoll, M. Ploug, and L. Ossowski. 2006. A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth. J. Biol. Chem. 281:14852–14863.
- Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50:760–763.
- Cunningham, O., A. Andolfo, M.L. Santovito, L. Iuzzolino, F. Blasi, and N. Sidenius. 2003. Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J. 22:5994–6003.
- Degryse, B., M. Resnati, R.P. Czekay, D.J. Loskutoff, and F. Blasi. 2005. Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J. Biol. Chem. 280:24792–24803.
- Deng, G., S.A. Curriden, S. Wang, S. Rosenberg, and D.J. Loskutoff. 1996. a. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J. Cell Biol. 134:1563–1571.
- Deng, G., G. Royle, S. Wang, K. Crain, and D.J. Loskutoff. 1996. b. Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin. J. Biol. Chem. 271:12716–12723.
- Fawcett, J., C.L. Holness, L.A. Needham, H. Turley, K.C. Gatter, D.Y. Mason, and D.L. Simmons. 1992. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature. 360:481–484.
- Fazioli, F., M. Resnati, N. Sidenius, Y. Higashimoto, E. Appella, and F. Blasi. 1997. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J. 16:7279–7286.
- Gardsvoll, H., B. Gilquin, M.H. Le Du, A. Menez, T.J. Jorgensen, and M. Ploug. 2006. Characterization of the functional epitope on the urokinase receptor. Complete alanine scanning mutagenesis supplemented by chemical cross-linking. J. Biol. Chem. 281:19260–19272.
- Gargiulo, L., I. Longanesi-Cattani, K. Bifulco, P. Franco, R. Raiola, P. Campiglia, P. Grieco, G. Peluso, M.P. Stoppelli, and M.V. Carriero. 2005. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide. J. Biol. Chem. 280:25225–25232.
- Gyetko, M.R., D. Aizenberg, and L. Mayo-Bond. 2004. Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro. J. Leukoc. Biol. 76:648–656.
- Høyer-Hansen, G., N. Behrendt, M. Ploug, K. Danø, and K.T. Preissner. 1997. The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction. FEBS Lett. 420:79–85.
- Huai, Q., A.P. Mazar, A. Kuo, G.C. Parry, D.E. Shaw, J. Callahan, Y. Li, C. Yuan, C. Bian, L. Chen, et al. 2006. Structure of human urokinase plasminogen activator in complex with its receptor. Science. 311:656–659.
- Jensen, J.K., M.K. Durand, S. Skeldal, D.M. Dupont, J.S. Bodker, T. Wind, and P.A. Andreasen. 2004. Construction of a plasminogen activator inhibitor-1 variant without measurable affinity to vitronectin but otherwise normal. FEBS Lett. 556:175–179.
- Jo, M., K.S. Thomas, D.M. O'Donnell, and S.L. Gonias. 2003. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor. J. Biol. Chem. 278:1642–1646.
- Kjøller, L., and A. Hall. 2001. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J. Cell Biol. 152:1145–1157.
- Laukaitis, C.M., D.J. Webb, K. Donais, and A.F. Horwitz. 2001. Differential dynamics of alpha 5 integrin, paxillin, and alpha-actinin during formation and disassembly of adhesions in migrating cells. J. Cell Biol. 153:1427–1440.
- Li, Y., D.A. Lawrence, and L. Zhang. 2003. Sequences within domain II of the urokinase receptor critical for differential ligand recognition. J. Biol. Chem. 278:29925–29932.
- Liang, O.D., K. Bdeir, R.L. Matz, T. Chavakis, and K.T. Preissner. 2003. Intermolecular contact regions in urokinase plasminogen activator receptor. J. Biochem. (Tokyo). 134:661–666.
- Liu, D., J.A. Ghiso, Y. Estrada, and L. Ossowski. 2002. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell. 1:445–457.
- Llinas, P., M.H. Le Du, H. Gardsvoll, K. Dano, M. Ploug, B. Gilquin, E.A. Stura, and A. Menez. 2005. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J. 24:1655–1663.
- Lund, L.R., K.A. Green, A.A. Stoop, M. Ploug, K. Almholt, J. Lilla, B.S. Nielsen, I.J. Christensen, C.S. Craik, Z. Werb, et al. 2006. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J. 25:2686–2697.
- Mazzieri, R., S. D'Alessio, R.K. Kenmoe, L. Ossowski, and F. Blasi. 2006. An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. Mol. Biol. Cell. 17:367–378.
- Nguyen, D.H., I.M. Hussaini, and S.L. Gonias. 1998. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J. Biol. Chem. 273:8502–8507.
- Nguyen, D.H., A.D. Catling, D.J. Webb, M. Sankovic, L.A. Walker, A.V. Somlyo, M.J. Weber, and S.L. Gonias. 1999. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J. Cell Biol. 146:149–164.
- Okumura, Y., Y. Kamikubo, S.A. Curriden, J. Wang, T. Kiwada, S. Futaki, K. Kitagawa, and D.J. Loskutoff. 2002. Kinetic analysis of the interaction between vitronectin and the urokinase receptor. J. Biol. Chem. 277:9395–9404.
- Resnati, M., I. Pallavicini, J.M. Wang, J. Oppenheim, C.N. Serhan, M. Romano, and F. Blasi. 2002. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. USA. 99:1359–1364.
- Roldan, A.L., M.V. Cubellis, M.T. Masucci, N. Behrendt, L.R. Lund, K. Danø, E. Appella, and F. Blasi. 1990. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J 9:467–474 (published erratum appears in EMBO J. 1990. May;9:1674).
- Selleri, C., N. Montuori, P. Ricci, V. Visconte, M.V. Carriero, N. Sidenius, B. Serio, F. Blasi, B. Rotoli, G. Rossi, and P. Ragno. 2005. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood. 105:2198–2205.
- Sidenius, N., and F. Blasi. 2000. Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin. FEBS Lett. 470:40–46.
- Sidenius, N., and F. Blasi. 2003. The urokinase plasminogen activator system in cancer: recent advances and implications for prognosis and therapy. Cancer Metastasis Rev. 22:205–222.
- Sidenius, N., A. Andolfo, R. Fesce, and F. Blasi. 2002. Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization. J. Biol. Chem. 277:27982–27990.
- Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:31–39.
- Stefansson, S., and D.A. Lawrence. 1996. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature. 383:441–443.
- Waltz, D.A., and H.A. Chapman. 1994. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269:14746–14750.
- Wei, Y., D.A. Waltz, N. Rao, R.J. Drummond, S. Rosenberg, and H.A. Chapman. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380–32388.
- Wei, Y., M. Lukashev, D.I. Simon, S.C. Bodary, S. Rosenberg, M.V. Doyle, and H.A. Chapman. 1996. Regulation of integrin function by the urokinase receptor. Science. 273:1551–1555.
- Wei, Y., X. Yang, Q. Liu, J.A. Wilkins, and H.A. Chapman. 1999. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J. Cell Biol. 144:1285–1294.
- Wei, Y., J.A. Eble, Z. Wang, J.A. Kreidberg, and H.A. Chapman. 2001. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol. Biol. Cell. 12:2975–2986.
- Wei, Y., C.H. Tang, Y. Kim, L. Robillard, F. Zhang, M.C. Kugler, and H.A. Chapman. 2007. Urokinase receptors are required for alpha5beta1 integrin-mediated signaling in tumor cells. J. Biol. Chem. 282:3929–3939.
Source: PubMed